Navigation Links
Labopharm Reports Results for Second Quarter Fiscal 2009
Date:8/7/2009

----------------- ------------------------------------------------------------------------- Net loss per share - basic and diluted (0.09) (0.18) (0.23) (0.35) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Weighted average number of common shares outstanding 56,839,127 56,821,651 56,832,673 56,819,919 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Labopharm Inc. INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended: For the six months ended: June 30, June 30, June 30, June 30, 2009 2008 2009 2008 (thousands of (Restated) (Restated) Canadian dollars) $ $ $ $ ------------------------------------------------------------------------- OPERATING ACTIVITIES Net loss for the period (4,874) (10,253) (12,848) (19,996) Items not affecting cash: Depreciation of property, plant and equipment 411 460 833 915 Amortization of intangible assets 42 30 83 60 Amortization of premiums and discounts on marketable securities 39 13 54 27 Impairment loss on long-term investment - - - 691 Non-cash financial expenses 148 92 290 187 Unrealized foreign exchange gain (1,643) (20) (835)
'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
2. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
3. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
4. Labopharm amends debt facility agreement with Hercules
5. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Labopharm announces details for first quarter results conference call and annual meeting
8. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
9. Labopharm to present at Cowen 29th Annual Health Care Conference
10. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
11. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 EBSCO Information ... (AMA) are expanding their relationship in an effort to further ... the world. While EBSCO has long made AMA journals available ... sales agent for The JAMA Network. , Long ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... too low when benefits are so high , , THURSDAY, ... at the levels health-care providers and policymakers would like, two ... , Representatives of the U.S. Centers for Disease Control and ... of the Department of Health and Human Services, are spending ...
... , , , TAMPA, ... Health Management Solutions for health plans, is named among the 5,000 fastest ... , , (Logo: http://www.newsco m ... The leading business magazine recognizes the nation,s fastest-growing, privately held ...
... , WASHINGTON, Aug. 13 The following ... Improving access to affordable, comprehensive health care has been ... of the America,s Affordable Health Choices Act (H.R. 3200) will make ... includes: , , , ...
... ... has done a summary analysis of the health care plan currently under consideration in Congress. ... the plan are simply not true (There is no coverage for illegal aliens, and the ... there is still serious concern on the financial side. , ...
... , NEW YORK, Aug. 13 His mission is to ... consequences. Chef Lindsey Williams, grandson of Sylvia Woods, owner of Sylvia,s ... ," a collection of traditional soul food dishes made with healthier cooking ... named after iconic Harlem figures this weekend during Harlem Week. ...
... , - Healthcare Reform Proposals in Congress Set ... by $130.2 Million over Ten Years - , , ... Mexico Congressional Delegation to Stop and Revise Further Cuts to Seniors, ... N.M., Aug. 13 Area nursing home caregivers, residents and family ...
Cached Medicine News:Health News:It's Time for More Moms to Breast-Feed, U.S. Officials Say 2Health News:It's Time for More Moms to Breast-Feed, U.S. Officials Say 3Health News:Health Integrated Named to the 2009 Inc. 5000 2Health News:Analysis of the Proposed Health Care Legislation Finds Financial Aspects May be Difficult to Forecast 2Health News:Queen of Soul Food's Grandson on Mission to Get Harlem Kids to Eat Healthier 2Health News:Queen of Soul Food's Grandson on Mission to Get Harlem Kids to Eat Healthier 3Health News:State, National Nursing Home Caregivers: Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New Mexico's Seniors 2Health News:State, National Nursing Home Caregivers: Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New Mexico's Seniors 3
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
(Date:1/22/2015)...  ViewRay™, a privately held medical device company, announced today ... with ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to ... of cancer in Japan . ViewRay,s ... and only MRI-guided radiation therapy system that images and ...
(Date:1/22/2015)...  Amgen (NASDAQ: AMGN ) today announced that it will ... Tuesday, Jan. 27, 2015, after the close of the U.S. financial ... the investment community at 2 p.m. PT. Participating in the call ... chief executive officer, and other members of Amgen,s senior management team. ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... N.J., June 2 Medarex, Inc.,(Nasdaq: ... a Phase 1/2 trial of,ipilimumab, an investigational ... radiotherapy in patients with metastatic castration,resistant prostate ... or in combination with radiotherapy was clinically ...
... June 2 "A two-year,survival rate of ... refractory anaplastic,astrocytoma suggests a breakthrough in this ... Bogdahn, Neuro-Oncologist and Coordinating,Investigator of the Phase ... recurrent or refractory high-grade glioma, while presenting ...
Cached Medicine Technology:Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 2Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 3Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 4Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: